NOVARTIS AG (NVSEF)
Clinical trial NCT05983198 updates: 1. completion date: 2029-11-05 → 2031-03-04 2. primary completion date: 2026-11-19 → 2031-03-04
Clinical trial NCT05983198 updates: 1. completion date: 2029-11-05 → 2031-03-04 2. primary completion date: 2026-11-19 → 2031-03-04
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical